16
Participants
Start Date
November 8, 2016
Primary Completion Date
June 26, 2018
Study Completion Date
December 15, 2019
Acipimox
Oral supplement containing Acipimox 250mgs as the active ingredient in blinded label tablet form.
placebo
The placebo supplement will contain only cellulose microcrystalline. This is an inert substance widely used in many pill and tablet formulations. It is an insoluble fibre and is not absorbed into the blood stream therefore is unlikely to cause toxicity when taken orally.
NIHR Exeter Clinical Research Facility, Exeter
University of Exeter
OTHER
Royal Devon and Exeter NHS Foundation Trust
OTHER